메뉴 건너뛰기




Volumn 16, Issue 3, 2016, Pages 255-261

Changes in Levels of Biomarkers Associated with Adipocyte Function and Insulin and Glucagon Kinetics During Treatment with Dapagliflozin Among Obese Type 2 Diabetes Mellitus Patients

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; DAPAGLIFLOZIN; GLUCAGON; GLUCAGON LIKE PEPTIDE 1 RECEPTOR AGONIST; GLUCOSE; HEMOGLOBIN A1C; IMMUNOREACTIVE INSULIN; INSULIN; KETONE BODY; PLASMINOGEN ACTIVATOR INHIBITOR 1;

EID: 84975501232     PISSN: 11745886     EISSN: 11796901     Source Type: Journal    
DOI: 10.1007/s40268-016-0137-9     Document Type: Article
Times cited : (51)

References (24)
  • 2
    • 0034641568 scopus 로고    scopus 로고
    • Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
    • COI: 1:STN:280:DC%2BD3cvisFWnsg%3D%3D, PID: 10938048
    • Stratton IM, Adler AI, Neil HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ. 2000;321:405–12.
    • (2000) BMJ. , vol.321 , pp. 405-412
    • Stratton, I.M.1    Adler, A.I.2    Neil, H.A.3
  • 3
    • 84989322701 scopus 로고    scopus 로고
    • Treatment guide for diabetes 2013-2014
    • Japanese Diabetes Society (ed). Treatment guide for diabetes 2013-2014. Tokyo: Japanese Diabetes Society; 2014.
    • (2014) Tokyo: Japanese Diabetes Society
  • 5
    • 84989314435 scopus 로고    scopus 로고
    • Japan Diabetes Clinical Data Management Study Group. Basic data tabulation (2013) [in Japanese] Accessed 15 Dec 2015.
    • Japan Diabetes Clinical Data Management Study Group. Basic data tabulation (2013) [in Japanese]. Available at: http://jddm.jp/study/index.html. Accessed 15 Dec 2015.
  • 6
    • 0035146344 scopus 로고    scopus 로고
    • Renal gluconeogenesis: its importance in human glucose homeostasis
    • COI: 1:CAS:528:DC%2BD3MXhtlKgsrc%3D, PID: 11213896
    • Gerich JE, Meyer C, Woerle HJ, et al. Renal gluconeogenesis: its importance in human glucose homeostasis. Diabetes Care. 2001;24:382–91.
    • (2001) Diabetes Care. , vol.24 , pp. 382-391
    • Gerich, J.E.1    Meyer, C.2    Woerle, H.J.3
  • 7
    • 84885171560 scopus 로고    scopus 로고
    • The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus
    • COI: 1:CAS:528:DC%2BC3sXhsVSitLrE, PID: 23744749
    • Riser Taylor S, Harris KB. The clinical efficacy and safety of sodium glucose cotransporter-2 inhibitors in adults with type 2 diabetes mellitus. Pharmacotherapy. 2013;33:984–99.
    • (2013) Pharmacotherapy , vol.33 , pp. 984-999
    • Riser Taylor, S.1    Harris, K.B.2
  • 8
    • 76249133903 scopus 로고    scopus 로고
    • Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications
    • COI: 1:CAS:528:DC%2BC3cXjvF2mtLg%3D, PID: 20546255
    • Gerich JE. Role of the kidney in normal glucose homeostasis and in the hyperglycaemia of diabetes mellitus: therapeutic implications. Diabet Med. 2010;27:136–42.
    • (2010) Diabet Med. , vol.27 , pp. 136-142
    • Gerich, J.E.1
  • 9
    • 57949111356 scopus 로고    scopus 로고
    • Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats
    • COI: 1:CAS:528:DC%2BD1cXhsFChurfO, PID: 19095325
    • Tabatabai NM, Sharma M, Blumenthal SS, et al. Enhanced expressions of sodium-glucose cotransporters in the kidneys of diabetic Zucker rats. Diabetes Res Clin Pract. 2009;83:e27–30.
    • (2009) Diabetes Res Clin Pract. , vol.83 , pp. e27-e30
    • Tabatabai, N.M.1    Sharma, M.2    Blumenthal, S.S.3
  • 10
    • 79960132085 scopus 로고    scopus 로고
    • A paradigm shift in diabetes therapy: dapagliflozin and other SGLT2 inhibitors
    • PID: 21447284
    • Chao EC. A paradigm shift in diabetes therapy: dapagliflozin and other SGLT2 inhibitors. Discov Med. 2011;11:255–63.
    • (2011) Discov Med. , vol.11 , pp. 255-263
    • Chao, E.C.1
  • 11
    • 0021813187 scopus 로고
    • Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man
    • COI: 1:CAS:528:DyaL2MXlslKnu7k%3D, PID: 3899825
    • Matthews DR, Hosker JP, Rudenski AS, et al. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985;28:412–9.
    • (1985) Diabetologia. , vol.28 , pp. 412-419
    • Matthews, D.R.1    Hosker, J.P.2    Rudenski, A.S.3
  • 12
    • 84914181817 scopus 로고    scopus 로고
    • Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise
    • COI: 1:CAS:528:DC%2BC2cXhslemtrfF, PID: 24909293
    • Kaku K, Kiyosue A, Inoue S, et al. Efficacy and safety of dapagliflozin monotherapy in Japanese patients with type 2 diabetes inadequately controlled by diet and exercise. Diabetes Obes Metab. 2014;16:1102–10.
    • (2014) Diabetes Obes Metab. , vol.16 , pp. 1102-1110
    • Kaku, K.1    Kiyosue, A.2    Inoue, S.3
  • 13
    • 84915738768 scopus 로고    scopus 로고
    • Dapagliflozin as monotherapy or combination therapy in Japanese patients with type 2 diabetes: an open-label study
    • COI: 1:CAS:528:DC%2BC2cXhvVGisLrN, PID: 25341477
    • Kaku K, Maegawa H, Tanizawa Y, et al. Dapagliflozin as monotherapy or combination therapy in Japanese patients with type 2 diabetes: an open-label study. Diabetes Ther. 2014;5:415–33.
    • (2014) Diabetes Ther. , vol.5 , pp. 415-433
    • Kaku, K.1    Maegawa, H.2    Tanizawa, Y.3
  • 14
    • 84891526739 scopus 로고    scopus 로고
    • Impact of sodium glucose cotransporter 2 inhibitors on weight in patients with type 2 diabetes mellitus
    • PID: 24113667
    • Barnett AH. Impact of sodium glucose cotransporter 2 inhibitors on weight in patients with type 2 diabetes mellitus. Postgrad Med. 2013;125:92–100.
    • (2013) Postgrad Med. , vol.125 , pp. 92-100
    • Barnett, A.H.1
  • 15
    • 84962339296 scopus 로고    scopus 로고
    • Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition
    • COI: 1:CAS:528:DC%2BC28XnsFGlsrk%3D, PID: 26078479
    • Peters AL, Buschur EO, Buse JB, Cohan P, Diner JC, Hirsch IB. Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition. Diabetes Care. 2015;38:1687–93.
    • (2015) Diabetes Care. , vol.38 , pp. 1687-1693
    • Peters, A.L.1    Buschur, E.O.2    Buse, J.B.3    Cohan, P.4    Diner, J.C.5    Hirsch, I.B.6
  • 16
    • 84858020943 scopus 로고    scopus 로고
    • Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin
    • COI: 1:CAS:528:DC%2BC38Xkt1yms78%3D, PID: 22238392
    • Bolinder J, Ljunggren Ö, Kullberg J, et al. Effects of dapagliflozin on body weight, total fat mass, and regional adipose tissue distribution in patients with type 2 diabetes mellitus with inadequate glycemic control on metformin. J Clin Endocrinol Metab. 2012;97:1020–31.
    • (2012) J Clin Endocrinol Metab , vol.97 , pp. 1020-1031
    • Bolinder, J.1    Ljunggren, Ö.2    Kullberg, J.3
  • 17
    • 84930087193 scopus 로고    scopus 로고
    • A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program
    • COI: 1:CAS:528:DC%2BC2cXhs1Kgt7fI, PID: 25267081
    • Zhang C, Luo H, Gao F, et al. A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program. Acta Diabetol. 2015;52(3):625–8.
    • (2015) Acta Diabetol. , vol.52 , Issue.3 , pp. 625-628
    • Zhang, C.1    Luo, H.2    Gao, F.3
  • 18
    • 84916603703 scopus 로고    scopus 로고
    • Effects of a community-based weight loss intervention on adipose tissue circulating factors
    • PID: 25293442
    • Miller GD, Isom S, Morgan TM, et al. Effects of a community-based weight loss intervention on adipose tissue circulating factors. Diabetes Metab Syndr. 2014;8:205–11.
    • (2014) Diabetes Metab Syndr. , vol.8 , pp. 205-211
    • Miller, G.D.1    Isom, S.2    Morgan, T.M.3
  • 19
    • 84893827104 scopus 로고    scopus 로고
    • Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production
    • COI: 1:CAS:528:DC%2BC2cXis1ersL0%3D, PID: 24463448
    • Merovci A, Solis-Herrera C, Daniele G, et al. Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production. J Clin Invest. 2014;124:509–14.
    • (2014) J Clin Invest. , vol.124 , pp. 509-514
    • Merovci, A.1    Solis-Herrera, C.2    Daniele, G.3
  • 20
    • 84893872877 scopus 로고    scopus 로고
    • Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients
    • COI: 1:CAS:528:DC%2BC2cXis1ers7c%3D, PID: 24463454
    • Ferrannini E, Muscelli E, Frascerra S, et al. Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients. J Clin Invest. 2014;124:499–508.
    • (2014) J Clin Invest. , vol.124 , pp. 499-508
    • Ferrannini, E.1    Muscelli, E.2    Frascerra, S.3
  • 21
    • 84937763347 scopus 로고    scopus 로고
    • Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion
    • COI: 1:CAS:528:DC%2BC2MXnvFSqurY%3D, PID: 25894829
    • Bonner C, Kerr-Conte J, Gmyr V, Queniat G, Moerman E, Thévenet J, et al. Inhibition of the glucose transporter SGLT2 with dapagliflozin in pancreatic alpha cells triggers glucagon secretion. Nat Med. 2015;21(5):512–7.
    • (2015) Nat Med. , vol.21 , Issue.5 , pp. 512-517
    • Bonner, C.1    Kerr-Conte, J.2    Gmyr, V.3    Queniat, G.4    Moerman, E.5    Thévenet, J.6
  • 22
    • 84889670998 scopus 로고    scopus 로고
    • Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes
    • COI: 1:CAS:528:DC%2BC3sXhvFOksL3O, PID: 24315372
    • Zhang Q, Ramracheya R, Lahmann C, Tarasov A, Bengtsson M, Braha O, et al. Role of KATP channels in glucose-regulated glucagon secretion and impaired counterregulation in type 2 diabetes. Cell Metab. 2013;18(6):871–82.
    • (2013) Cell Metab. , vol.18 , Issue.6 , pp. 871-882
    • Zhang, Q.1    Ramracheya, R.2    Lahmann, C.3    Tarasov, A.4    Bengtsson, M.5    Braha, O.6
  • 23
    • 84887147788 scopus 로고    scopus 로고
    • Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study
    • COI: 1:CAS:528:DC%2BC3sXhslCrs7%2FO, PID: 23782594
    • Inagaki N, Kondo K, Yoshinari T, et al. Efficacy and safety of canagliflozin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, 12-week study. Diabetes Obes Metab. 2013;15:1136–45.
    • (2013) Diabetes Obes Metab. , vol.15 , pp. 1136-1145
    • Inagaki, N.1    Kondo, K.2    Yoshinari, T.3
  • 24
    • 84872166360 scopus 로고    scopus 로고
    • Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor
    • COI: 1:CAS:528:DC%2BC3sXjvVCnsA%3D%3D, PID: 23223453
    • Shimazu T, Hirschey MD, Newman J, et al. Suppression of oxidative stress by β-hydroxybutyrate, an endogenous histone deacetylase inhibitor. Science. 2013;339:211–4.
    • (2013) Science. , vol.339 , pp. 211-214
    • Shimazu, T.1    Hirschey, M.D.2    Newman, J.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.